Mantle cell lymphoma (MCL) is a subtype of non-Hodgkin lymphoma characterized by the proliferation of B-cells in the mantle zone of lymphoid follicles. When MCL affects the intrapelvic lymph nodes, it can lead to significant clinical complications, including abdominal pain and lymphadenopathy. Accurate coding with ICD-10 Code C83.16 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that patients receive appropriate care and resources.
What is ICD-10 Code C83.16 for Mantle cell lymphoma, intrapelvic lymph nodes?
ICD-10 Code C83.16 specifically denotes mantle cell lymphoma localized to the intrapelvic lymph nodes. This condition arises from the malignant transformation of B-lymphocytes and is associated with various clinical manifestations. The code should be used in clinical documentation and billing when a patient is diagnosed with MCL affecting the intrapelvic lymph nodes, ensuring accurate representation of the patient's condition for treatment and reimbursement purposes.
ICD-10 Code C83.16 – Clinical Definition and Explanation of Mantle cell lymphoma, intrapelvic lymph nodes
Mantle cell lymphoma, particularly when localized to the intrapelvic lymph nodes, is a serious hematological malignancy that requires prompt medical attention. The condition is caused by genetic mutations leading to uncontrolled B-cell proliferation. It can progress rapidly, necessitating early diagnosis and intervention.
Key Clinical Features:
- Presence of enlarged intrapelvic lymph nodes, often detected via imaging.
- Symptoms may include abdominal discomfort, weight loss, and fatigue.
- Potential for systemic symptoms such as fever and night sweats.
- Higher prevalence in older adults, particularly males.
ICD-10 Code C83.16 for Mantle cell lymphoma, intrapelvic lymph nodes – SOAP Notes & Clinical Use
ICD-10 Code C83.16 is utilized in SOAP notes to document the diagnosis of mantle cell lymphoma affecting the intrapelvic lymph nodes. It plays a crucial role in capturing patient symptoms, clinical assessments, and treatment plans, relevant in both acute and chronic care settings.
What Does ICD-10 Code C83.16 for Mantle cell lymphoma, intrapelvic lymph nodes Mean in SOAP Notes?
In SOAP notes, ICD-10 Code C83.16 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of mantle cell lymphoma in the intrapelvic lymph nodes. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.
Treatment Options for ICD-10 Code C83.16 – Mantle cell lymphoma, intrapelvic lymph nodes
Prompt treatment for mantle cell lymphoma affecting the intrapelvic lymph nodes is critical due to its aggressive nature. Treatment may include chemotherapy, targeted therapy, or stem cell transplantation.
Antibiotic Therapy:
- Not applicable as mantle cell lymphoma is not an infectious condition.
Supportive Care:
- Pain management strategies, including analgesics.
- Nutritional support to address weight loss.
- Psychosocial support for emotional well-being.
Infection Control:
- Standard precautions to prevent infections in immunocompromised patients.
- Monitoring for signs of infection due to chemotherapy.
How to Document Symptoms of Mantle cell lymphoma, intrapelvic lymph nodes (ICD-10 C83.16) in SOAP Notes
Subjective:
- Patient reports persistent abdominal pain and discomfort.
- History of unexplained weight loss over the past few months.
- Complaints of fatigue and decreased appetite.
- No prior history of lymphoma or significant medical conditions.
Objective:
- Physical examination reveals enlarged intrapelvic lymph nodes.
- Abdominal ultrasound shows lymphadenopathy in the pelvic region.
- Laboratory tests indicate elevated lactate dehydrogenase (LDH) levels.
- CT scan confirms the presence of mantle cell lymphoma.
Secure, compliant, and built for trust
HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn more
SOAP Note Guidelines for Diagnosing Mantle cell lymphoma, intrapelvic lymph nodes (ICD-10 Code C83.16)
Assessment:
- Diagnosis: Mantle cell lymphoma, intrapelvic lymph nodes, classified as aggressive.
- ICD-10 Code: C83.16.
- Contributing factors include age and male gender.
- No known triggers identified.
Plan:
- Initiate chemotherapy regimen tailored for mantle cell lymphoma.
- Provide education on disease management and treatment expectations.
- Schedule regular follow-up appointments for monitoring response to treatment.
- Consider referral to oncology for specialized care.
Treatment & Plan Section for ICD-10 Code C83.16 – Mantle cell lymphoma, intrapelvic lymph nodes
- First-line treatment typically includes a combination of chemotherapy agents such as cyclophosphamide, doxorubicin, vincristine, and prednisone.
- Non-pharmacologic strategies include nutritional counseling and psychosocial support.
- Monitoring includes regular imaging studies and laboratory tests to assess treatment response.
- Follow-up practices involve ongoing assessment of symptoms and side effects.
Using ICD-10 Code C83.16 for Mantle cell lymphoma, intrapelvic lymph nodes in Billing & SOAP Note Compliance
- Select accurate subcodes based on clinical severity or complications.
- Document symptoms clearly under Subjective (S) and Objective (O) in SOAP notes.
- Ensure treatment plans align with clinical guidelines to support justified billing.
- Only list CPT codes that are commonly billed with ICD-10 Code C83.16 based on standard medical coding practices.
Related ICD-10 Codes Often Used with Mantle cell lymphoma, intrapelvic lymph nodes
- C83.17 – Mantle cell lymphoma, other lymph nodes
- C82.89 – Other follicular lymphoma
- C83.19 – Mantle cell lymphoma, unspecified
ICD-10 Code C83.16 in Medical Billing and Insurance for Mantle cell lymphoma, intrapelvic lymph nodes
ICD-10 Code C83.16 is crucial for accurate billing in hospital, ER, or infectious disease care settings.
Billing Notes:
- Ensure thorough documentation of the diagnosis and treatment plan to support claims.
- Use this code in conjunction with relevant CPT codes for comprehensive billing.
- Include key chart elements such as patient history, examination findings, and treatment response.
- Verify coding accuracy to prevent claim denials.
Common CPT Pairings:
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push, single or initial substance. |
| 99214 | Established patient office visit, moderate complexity. |
| 85025 | Complete blood count with automated differential. |
| 77014 | Ultrasound guidance for needle placement. |
Frequently Asked Questions
Common Questions About Using ICD-10 Code C83.16 for Mantle cell lymphoma, intrapelvic lymph nodes
What are the common symptoms of mantle cell lymphoma?
Common symptoms include swollen lymph nodes, abdominal pain, fatigue, and unexplained weight loss. Patients may also experience fever and night sweats, which are indicative of systemic involvement.
How is mantle cell lymphoma diagnosed?
Diagnosis typically involves imaging studies such as CT scans, biopsy of affected lymph nodes, and laboratory tests to assess blood counts and markers specific to lymphoma.
What treatments are available for mantle cell lymphoma?
Treatment options include chemotherapy, targeted therapy, and stem cell transplantation. The choice of treatment depends on the stage of the disease and the patient's overall health.
Is mantle cell lymphoma curable?
While mantle cell lymphoma is considered aggressive and challenging to treat, advancements in therapy have improved outcomes. Some patients achieve remission, but ongoing management is often necessary.
